• 제목/요약/키워드: Meningococcal disease

검색결과 7건 처리시간 0.026초

Meningococcal Disease and Quadrivalent MenACWY-CRM Vaccine (Menveo®)

  • Tsai, Theodore F.
    • Pediatric Infection and Vaccine
    • /
    • 제19권3호
    • /
    • pp.89-110
    • /
    • 2012
  • Meningococcal Disease, manifesting as meningitis and septicemia, is a life-threatening bacterial infection that results in significant morbidity and mortality, particularly in childhood. Its epidemic potential and limited opportunities for clinical intervention due to its rapid course present unique public health and clinical challenges. Incidence is highest in infants and young children, with a secondary peak of risk in adolescents. Approximately 10% of cases are fatal and survivors can be left with serious and permanent sequelae including amputations, hearing loss and cognitive impairment. Transmission is only from human-to-human, by infected respiratory tract secretions or saliva and therefore crowding poses a tremendously elevated risk for disease development. Military recruits and university students are at high risk due to the high carriage rate in adolescents, their behavior patterns and close contact. Menveo$^{(R)}$ (Novartis Vaccines and Diagnostics), a novel quadrivalent meningococcal conjugate vaccine directed against meningococcal serogroups A, C, W-135 and Y, has been shown to be immunogenic and well tolerated in all age groups and was recently licensed for use in Korea. Recent cases and deaths among military recruits drew public attention to their elevated risk and the Korean government has recommended vaccination of all new military recruits. Many Korean students seek to attend school, university, or language institutes in countries where routine meningococcal vaccination is required - clinicians should be aware of such requirements to ensure that students are vaccinated prior to arrival in the destination country.

  • PDF

A군 연구균 감염 후 급성 사구체 신염과 동반된 침습성 수막구균감염증 1례 (Case of Combined Acute Poststreptococcal Glomerulonephritis and Acute Invasive Meningococcal Disease)

  • 전호상;한원호;박동균;차성호
    • Pediatric Infection and Vaccine
    • /
    • 제11권1호
    • /
    • pp.126-130
    • /
    • 2004
  • 본 저자들은 A군 연쇄구균 감염 후 급성 사구체신염과 동반된 수막구균감염증(수막구균 뇌수막염, 수막구균혈증)에 걸린 7세 남아를 경험하였는데 A군 연쇄구균 감염 후 급성 사구체 신염으로 인해서 C3가 감소하여 수막구균감염증에 감염이 되었는지, 역으로 가능성은 떨어지지만 수막구균감염증의 결과로 C3가 감소하였고 사구체신염이 생긴 것인지 전후 관계가 확실하지 않은 증례를 문헌고찰과 함께 보고하는 바이다.

  • PDF

Laboratory Confirmation of A Suspicious Meningococcal Meningitis Death Case

  • Zhang Tie-Gang;He Xiong;Chen Li-Juan;He Jing-Guo;Luo Ming;Yang Jie;Shao Zhu-Jun;Sun Mei-Ping
    • Journal of Microbiology
    • /
    • 제44권4호
    • /
    • pp.457-460
    • /
    • 2006
  • A suspicious meningococcal meningitis death case was reported to the Beijing CDC. The blood specimen was analyzed via multi-PCR and MLST. 6 isolates from close contacts were analyzed via PFGE and MLST. According to the results of the above analyses, the cause of this case was identified as a serogroup A Neisseria meningitidis, which, in terms of sequence typing, belonged the ST7 group.

Neonatal Sepsis and Meningitis Caused by Neisseria meningitidis Serogroup B: a Case Report

  • Kim, Yoo Na;Choi, Yong-Sung;Cha, Sung Ho
    • Pediatric Infection and Vaccine
    • /
    • 제25권3호
    • /
    • pp.165-169
    • /
    • 2018
  • 수막구균 감염은 신생아에서 높은 사망률을 보이지만 매우 드물고, 단체 생활하는 연장아나 청소년에서 더 흔하다고 알려져 있다. 이 증례에서 소개된 생후 16일 신생아는 수막구균 B 혈청군 패혈증과 수막염이 진단되었지만 조기 항생제 치료를 통해 합병증 없이 건강하게 퇴원하였다. 이 증례 보고의 목적은 신생아에서 수막구균 감염의 발생률과 중요성을 상기시키고 노출된 가족들과 의료진에 대한 조사와 예방 요법의 필요성을 강조하기 위함이다. 한국에서는 많은 신생아가 출생 후 산후조리원 시설에서 지내내므로 감염 발생과 전파에 단체 생활이 영향을 미칠 수도 있음을 생각해 볼 필요가 있다. 질병의 조기 발견, 격리, 그리고 경험적 치료가 치명적인 질병의 전파를 예방하기 위해 매우 중요하다.

보체 인자 9 결핍을 동반한 수막구균성 수막염 1례 (A Case of Meningococcal Meningitis with Complement 9 Deficiency)

  • 최선미;이경일;이형신;홍자현;이미희;이병철
    • Clinical and Experimental Pediatrics
    • /
    • 제48권1호
    • /
    • pp.101-103
    • /
    • 2005
  • 저자들은 12세 여아로 수막구균 수막염에 이환 후 시행한 보체 검사에서 C9 결핍을 확인한 1례를 경험하였다. 수막구균 수막염에 이환된 환아에 대한 보체 검사는 보체 결핍을 갖는 환자와 가족 내 위험이 있는 사람을 찾아내어, 향후 예방접종 등의 예방과 감염 관리에 필요하다.

The Molecular Characterization of Serogroup C Neisseria meningitidis Strains Circulating in Beijing

  • Zhang, Tie-Gang;He, Jing-Guo;He, Xiong;Chen, Li-Juan;Shao, Zhu-Jun;Sun, Mei-Ping
    • Journal of Microbiology
    • /
    • 제44권6호
    • /
    • pp.685-688
    • /
    • 2006
  • The aim of this study was to characterize the molecular features of serogroup C Neisseria meningitidis strains circulating in Beijing, China. Twenty out of 23 strains belonged to ST 4821. The causative serosubtype for meningococcal meningitis was P1.12-1,16-8. All of the strains expressed class 3 PorB protein. Among the five pulsed-field gel electrophoresis patterns observed, pattern III predominated.

전염병관리 관련법령의 변화 추이분석 및 향후 개정방향에 관한 연구 (The amendment tendency analysis of the Korean Infectious Disease Prevention Act and a recommendation for the next amendment)

  • 황창용;오희철;이덕형;박기동;이종구
    • Journal of Preventive Medicine and Public Health
    • /
    • 제31권3호
    • /
    • pp.540-563
    • /
    • 1998
  • This Study has been carried out to make a recommendation for the next amendment of the Infectious Disease Prevention Act with a specific focus on the kind of notifyable disease. Korean, Japanese, German, U.S, English and French acts on infectious diseases prevention were reviewed, compared with and analized in regards of numbers and kinds of notifyable infectious diseases and their tendency of amendments. An criteria was designed to assess the level of validity of diseases to be designated in the act. Four items, the fatality (greater than 10% or not), the possibility to make a big epidemic, the availability of efficient vaccination and the usefulness of isolation, are used in the assessment. This index is applied to the diseases in Korean and other countries' Infectious Disease Prevention Acts. Results are as follows: 1. The Korean Infectious Disease Preventon Act has a unique way of classifying the notifyable infectious disease, that is, the first, the second and the third class. But the author cannot find the basis of classification. No other countries reviewed have the similar classification. 2. The ten diseases, cholera, plague, yellow fever, diphtheria, typhoid fever, poliomyelitis, rabies, tetanus, malaria, and meningococcal meningitis are designated as the notifyable diseases not only in Korea but also in Japan, Germany, United States, England and france. 3. Thirty seven diseases including small pox, Lassa fever, anthrax, influenza, German measles, Legionellosis, infection with E. coli O157:H7, Q-fever, brucellosis, Lyme disease are designated as legal disease at least one of the above mentioned countries. 4. The Korea has been coped with the change of the infectious disease occurrence for last fifty years in amendment of the Infectious Disease Prevention Act. 5. Japan has a special infectious surveillance system composed of 3,880 clinics throughout the whole country. 6. Germany has classified infectious diseases in five categories which are based on seriousness of disease. Any confirmed death, cases and suspected cases in class I should be reported within 24 hours. But only confirmed death and cases in class II, but not suspected cases, are reportable in Germarny. 7. Plague, bacillary dysentery, pertussis, mumps, Japanese encephaltis and Korean hemorrhagic fevers are diseases with high credits validity index among Korean legal disease. 8. German measles, anthrax, E. coli O157 : H7 infection, Lassa fever, Q-fever, brucellosis are high in validity index among those which are not designated in Korea but designated in other countries. In conclusion, the Korean Infectious Disease Prevention Act has well been coped with the changes of infectious disease occurrence for last fifty years, but the classification basis and the validity of diseases to be designated as legal diseases is worth reevaluating.

  • PDF